Logo

Labcorp Launched Neurofilament Light Chain Blood Test to Identify Neurodegenerative Disease

Share this
Labcorp Launched Neurofilament Light Chain Blood Test to Identify Neurodegenerative Disease

Labcorp Launched Neurofilament Light Chain Blood Test to Identify Neurodegenerative Disease

Shots:

  • The company launched the new NfL blood test that allows doctors to identify and verify signs of neurodegenerative disease along with diagnosing and treat patients more quickly & effectively
  • The test measures key biomarkers associated with neuronal damage; assists in the diagnosis of diseases incl. MS, AD Parkinson’s, or brain injury. It is anticipated that having a wide range of diagnostic tools available to doctors will have a positive impact on the ability to diagnose & treat numerous conditions more successfully
  • The test's launch and availability showed Labcorp's dedication to neurology and to enhance the health and lives of people suffering from neurodegenerative and related disorders

Ref: Bussinesswire | Image: Labcorp

Click here to­ read the full press release 

Neha

Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions